Archives: Agenda

• Creating a shared understanding of clinical development and operational fundamentals for teams rooted in discovery science
• Leveraging external partners efficiently – CROs, consultants, vendors -especially when in-house experience is limited
• Building lightweight processes that educate and empower, rather than overwhelm
• Managing a “learning by doing” culture – iterative planning, open communication, and mentorship across disciplines

• Building flexibility into outsourcing partnerships for scalability
• Cost, quality and efficiency trade-offs between different models
• Identifying which model fits different phases of clinical development
• What does transition look like to you and how feasible is it?

Seats available

• Implementing an improved strategy of pipeline focusing on market, time and investment in clinical trials
• Aligning the reimbursement ecosystem to be operationally efficient
• Optimizing the funding infrastructure to avoid bankruptcy or being bought out
• Taking control of finances to deliver seamless trials and getting products approved
• How is clinical data being presented to investors and shareholders and how does it affect the way they perceive the budgets
• Bringing in major venture capitalist who work in early stages of clinical trials

• Designing lean, focused studies to generate meaningful results
• Leveraging strategic partnerships to stretch resources
• Maximizing the value of every dataset through smart analysis and clear storytelling
• Presenting compelling data to investors, partners and regulators with credibility and clarity

• Addressing recent site performance concerns and rebuilding trust when site credibility is questioned
• Identifying common gaps in oversight, governance to avoid actively monitoring site work
• Understanding policies and competing with limited resources at sites
• Enhancing site staff training, culture and accountability of clinical research